Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain

Objectives: To describe the epidemiology, clinical profile, treatments, and to determine cardiovascular and renal outcomes after two years of follow-up in a contemporary chronic kidneay disease (CKD) population in Spain. This was also analyzed among the DAPA-CKD-like population (patients who met mos...

Full description

Bibliographic Details
Published in:	Nefrología (English Edition)
Main Authors:	Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Antoni Sicras, Aram Sicras, Antonio Hormigo, Roberto Alcázar, Nicolás Manito, Manuel Botana
Format:	Article
Language:	English
Published:	Elsevier 2021-11-01
Subjects:	DAPA-CKD Muerte Enfermedad renal crónica Hospitalización Medicación Eventos
Online Access:	http://www.sciencedirect.com/science/article/pii/S2013251422000104

Similar Items

Hospitalized child and teenager with chronic diseases: feelings about death
by: Flávia Moura de Moura, et al.
Published: (2015-12-01)

Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular risk
by: Ana Cebrian, et al.
Published: (2024-03-01)

Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular risk
by: Ana Cebrian, et al.
Published: (2024-03-01)

Significado de la comodidad para pacientes crónicos hospitalizados
by: Yadira Cardozo García, et al.
Published: (2021-08-01)

Errores de medicación en pacientes hospitalizados: una revisión sistemática
by: Cristina Bohórquez-Moreno, et al.
Published: (2021-09-01)

La adherencia terapéutica en las enfermedades crónicas no trasmisibles
by: Alfredo Dario Espinosa Brito
Published: (2016-09-01)

Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease
by: Minara S. Shamkhalova, et al.
Published: (2022-11-01)

Compreendendo o significado de estar hospitalizado no cotidiano de crianças e adolescentes com doenças crônicas
by: Juliana Homem da Luz, et al.
Published: (2012-12-01)

Cardiovascular and renal outcomes according to KDIGO stages of chronic kidney disease in the Spanish population: Insights from real-world evidence
by: Rafael Santamaria, et al.
Published: (2025-10-01)

Increasing trend in patients with life-limiting and complex chronic conditions
by: Javier Ochoa-Brezmes, et al.
Published: (2024-08-01)

Nao adesao ao tratamento medicamentoso continuo: prevalencia e determinantes em adultos de 40 anos e mais
by: Felipe Assan Remondi, et al.
Published: (2014-01-01)

Estrategias de enfermería para reducir eventos adversos en pacientes hospitalizados
by: Karen Noemí España Olvera, et al.
Published: (2025-07-01)

Perfil das internações por doenças crônicas não-transmissíveis sensíveis à atenção primária em idosos da metade sul do RS
by: Vilma Constancia Fioravante dos Santos, et al.

Evolución de las causas de defunción en una ciudad de África occidental: Banjul, 1942-1997
by: Marianne A.B. van der Sande, et al.

Results of the DAPA-CKD trial and their impact on clinical practice
by: O.V. Bilchenko
Published: (2023-06-01)

Adherencia terapéutica en pacientes con diabetes mellitus tipo 2
by: Yamila Ramos Rangel, et al.
Published: (2017-06-01)

The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists
by: Michele Provenzano, et al.
Published: (2022-03-01)

Contando história de paciente
by: Lizete Pontes Macário Costa
Published: (2008-03-01)

External validation of a predictive model for one-year mortality in incident hemodialysis patients: A Portuguese cohort
by: Telma Pais, et al.
Published: (2025-08-01)

Out-of- hospital mortality in the municipality of Cienfuegos, 2016
by: Orlando Morera Álvarez, et al.
Published: (2020-02-01)

Hospitalización y mortalidad según adherencia al tratamiento farmacológico en pacientes con Diabetes Mellitus tipo 2
by: Veline Martínez
Published: (2022-01-01)

DYSLIPIDEMIA IN PATIENTS WITH DIABETIC KIDNEY DISEASE. OBJECTIVES OF TREATMENT. USE OF LIPID-LOWERING DRUGS
by: Carlos Buso
Published: (2018-08-01)

Clinical and epidemiologic characteristics in patients hospitalized due to heart failure
by: Lucia Nivia Turro Mesa, et al.
Published: (2023-05-01)

Association Between Coronary Calcium Detection on Chest Computed Tomography and Ischemic Cardiovascular Events and Mortality in Asymptomatic Chronic Obstructive Pulmonary Disease Patients. Systematic Review of the Literature
by: Miguel Jiménez-Gómez, et al.
Published: (2024-10-01)

EXPERIENCIAS DE MADRES DE NIÑOS CRÓNICOS DEPENDIENTES DE TECNOLOGÍA EN UNA UNIDAD DE CUIDADOS INTENSIVOS PEDIÁTRICOS
by: Brendo Vitor Nogueira Sousa, et al.
Published: (2023-08-01)

Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy
by: Marian Goicoechea, et al.
Published: (2021-11-01)

Variabilidad estacional de hospitalizaciones por varicela en el INSN, Lima-Perú
by: Edwin Miranda-Choque, et al.
Published: (2013-04-01)

Deceased patients with chronic kidney disease. Characteristics and causes in Cuba during 2011-2016
by: Maria del Carmen Marin Prada, et al.
Published: (2021-07-01)

Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project
by: Juan F. Navarro González, et al.
Published: (2024-11-01)

Efficacy and safety of the PCSK9 inhibitors in the treatment of dyslipidemia in chronic kidney disease
by: Borja Quiroga, et al.
Published: (2020-09-01)

Report from the 5th cardiovascular outcome trial (CVOT) summit
by: Oliver Schnell, et al.
Published: (2020-04-01)

Interrupciones durante la administración de medicamentos de alto riesgo: estudio transversal
by: Olga Lucia Gaitan-Gomez, et al.
Published: (2024-05-01)

Adherence to anti-hypertensive treatment within a chronic disease management  program: A longitudinal, retrospective study
by: Ana Carolina Nascimento Raymundo, et al.
Published: (2014-10-01)

Characterization of Type 2 Diabetics with Vascular Complications in Relation to Adherence to Treatment
by: Yadelaicy Ochoa González, et al.
Published: (2023-06-01)

Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
by: S. N. Tereshchenko, et al.
Published: (2020-06-01)

Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care
by: Jordi Bover, et al.
Published: (2024-03-01)

Riesgo de muerte por insuficiencia cardiaca congestiva en pacientes anémicos de la población peruana
by: Alberto Guevara Tirado
Published: (2023-07-01)

Caracterización clínica y epidemiológica de pacientes con falla cardiaca aguda
by: Rodrigo Zubieta-Rodríguez, et al.
Published: (2024-07-01)

Hypertension and diabetes-related morbidity and mortality trends in a municipality in the countryside of São Paulo
by: Andreia Francesli Negri Reis, et al.
Published: (2015-12-01)

Dapagliflozin attenuates atrial fibrosis via the HMGB1/RAGE pathway in atrial fibrillation rats
by: Tan Zhenni, et al.
Published: (2025-09-01)